- Nachrichtendetail
-
04.04.2024 12:53:46 - dpa-AFX: *MERCK INITIATES PHASE 3 TRIAL OF MK-1084 WITH FOR FIRST-LINE TREATMENT OF CERTAIN PATIENTS WITH METASTATIC NSCLC
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
MERCK CO. DL-,01 | A0YD8Q | Xetra | 121,800 | 30.04.24 17:35:41 | -0,600 | -0,49% | 0,000 | 0,000 | 121,600 | 121,800 |
